Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The industrial equipment and medical equipment markets generally remained firm, while sales to China were strong. Profitability improved as sales to the industrial equipment market expanded, higher revenue had a positive impact, and capacity utilisation increased.
None. The notes on the going concern assumption state: “There are no applicable matters.”
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥7,844 million (YoY +28.8%) |
| Operating profit | ¥424 million (YoY +171.3%) |
| Ordinary income | ¥434 million (YoY +112.6%) |
| Profit attributable to owners of the parent | ¥238 million (YoY +76.6%) |
| Net income per share | ¥32.72 |
| Equity ratio | End of the current fiscal period 77.3 / End of previous period 80.7 |
| Total assets | ¥20,409 million |
| Net assets | ¥15,768 million |
| Cash flows from operating activities | ¥253,619 thousand |
| Cash flows from investing activities | ¥-615,567 thousand |
| Cash flows from financing activities | ¥166,476 thousand |
| Cash and cash equivalents at end of period | ¥4,578,457 thousand |
| Full-year earnings forecast | Net Sales ¥15,600 million (YoY +21.3%) / Operating profit ¥1,000 million (YoY +251.1%) / Ordinary income ¥1,000 million (YoY +160.1%) / Profit attributable to owners of the parent ¥540 million (YoY +156.7%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥15,600 million / Operating profit Not disclosed → ¥1,000 million / Ordinary income Not disclosed → ¥1,000 million / Profit attributable to owners of the parent Not disclosed → ¥540 million |
| Annual Dividend Forecast | 80 Yen → 80 Yen(0.0%) |
| Regional sales | Region Japan / Net Sales ¥4,362 million / Year on year against the same period last year ¥18.7 million, Region China / Net Sales ¥2,037 million / Year on year against the same period last year ¥93.2 million, Region Other Asia / Net Sales ¥843 million / Year on year against the same period last year ¥14.1 million, Region Europe / Net Sales ¥447 million / Year on year against the same period last year ¥-9.2 million, Region North and Central America / Net Sales ¥152 million / Year on year against the same period last year ¥19.8 million, Region Total / Net Sales ¥7,844 million / Year on year against the same period last year ¥28.8 million |
| Depreciation and amortization | ¥443,450 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Item Costs related to measures addressing product defects / Amount ¥47,434 thousand, Item Loss on disposal of fixed assets / Amount ¥0 thousand |
| Disclosure regarding the going concern assumption | None. The notes on the going concern assumption state: “There are no applicable matters.” |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not applicable |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (audience: Not disclosed) |
| Issued Shares at Period-End | 7,743,000 |
| Treasury Shares at Period-End | 467,662 |
| Factors Behind Changes in Business Performance | The industrial equipment and medical equipment markets generally remained firm, while sales to China were strong. Profitability improved as sales to the industrial equipment market expanded, higher revenue had a positive impact, and capacity utilisation increased. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The industrial equipment market, primarily for semiconductor manufacturing equipment and factory automation equipment, and the medical equipment market remained firm, while sales to China were also strong. Profitability improved as sales to the core industrial equipment market expanded, higher revenue had a positive impact, and capacity utilisation increased.